No detectable improvements in CFTR by nasal aminoglycosides in CF patients heterozygous for stop mutations. Am J Resp Molec Cell Biol Clancy JP, Rowe SM, Bebok Z, Aitken ML, Gibson RL, Zeitlin P, Berclaz Y, Moss R, Knowles M, Oster RA, Mayer-Ham 2007; 37: 57-66